Results 141 to 150 of about 25,830 (222)

Antimicrobial Activity of D-Form Synthetic Peptides Against Metronidazole-Resistant and Susceptible <i>Trichomonas vaginalis</i>: A Comparative Transcriptomic Analysis. [PDF]

Int J Mol Sci
Özden Ö, Polat T, Kocagöz T, Kurt Ö.
europepmc   +1 more source

Multidose Metronidazole Treatment for Trichomonas vaginalis More Effective Than Single-Dose Treatment in Clinical Practice: A Retrospective Cohort Study. [PDF]

Sex Transm Dis
Ciuffetelli I, Albright N, Riggins A, Shuford J, Eco S, Wall KM, Young MR.   +6 more
europepmc   +1 more source

Analysis of a rare case of vaginitis caused by Trichomonas vaginalis combined with fungal infection. [PDF]

BMC Infect Dis
Chen C, Wang Q.
europepmc   +1 more source

The role of neutrophils in the pathogenesis of Trichomonas vaginalis infection in pregnant women: A review. [PDF]

Medicine (Baltimore)
Obeagu EI, Okoroiwu GI, Ubosi NI, Obeagu GU, Ayogu EE, Elamin E.   +5 more
europepmc   +1 more source

Chromosome-level genome assembly of Trichomonas vaginalis strain IR-78 (ATCC 50138). [PDF]

Sci Data
Abdel-Glil MY, Solle J, Neubauer H, Sprague LD.   +3 more
europepmc   +1 more source

<i>Trichomonas vaginalis</i> Virus: Current Insights and Emerging Perspectives. [PDF]

Viruses
Graves KJ, Novak J, Muzny CA.
europepmc   +1 more source

Inhibitors of the 20S proteasome β5 subunit as potent and selective agents against <i>Trichomonas vaginalis</i>. [PDF]

Antimicrob Agents Chemother
Miyamoto Y, Hurysz BM, Fajtova P, Eckmann P, Serafim MSM, Kronenberger T, Al-Hindy M, Dekker PM, Maurits E, Overkleeft HS, Bergdahl BM, Almaliti J, Gerwick WH, O'Donoghue AJ, Eckmann L.   +14 more
europepmc   +1 more source

Systematic review and meta-analysis of the global prevalence and infection risk factors of Trichomonas vaginalis. [PDF]

Parasite
Tian W, Li Y, Zhang Y, Zhang Y, Qin Y, Han Y, Li D, Wang S, Yang Z, Tian X, Mei X, Zhang Z.   +11 more
europepmc   +1 more source

Leveraging current capacity to address the high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in South Africa: Modelling potential costs and benefits of near point-of-care GeneXpert testing for STIs. [PDF]

PLOS Glob Public Health
Lekodeba NA, Snyman K, Nichols BE, Jamieson L.   +3 more
europepmc   +1 more source

Refining <i>Trichomonas vaginalis</i> treatment in women and men: protocol for an open-label randomised comparison of multi-dose oral metronidazole versus single-dose oral secnidazole. [PDF]

BMJ Open
Muzny CA, Lillis RA, Chavoustie SE, Arbuckle JL, Van Gerwen OT, Sagoe M, Kandregula AR, Srivastav S, Kissinger PJ.   +8 more
europepmc   +1 more source